Toxicant Exposures After Switching From Cigarettes to a Pod-Based Electronic Cigarette: A Randomized Clinical Trial

Area of Science:

• Tobacco regulatory science
• Addiction medicine
• Clinical toxicology

Background:

• Electronic cigarettes (ECs) may offer reduced toxicant exposure compared to combustible cigarettes.
• The rapid shift to pod-based nicotine salt formulations necessitates research on their impact on smokers.
• Understanding the effects of switching from cigarettes to ECs is crucial for public health.

Purpose of the Study:

• To evaluate the short-term effects of switching from cigarettes to a 5% nicotine pod-based EC versus a 0% nicotine EC.
• To assess changes in toxicant exposure and smoking cessation rates among adult smokers.

Main Methods:

• A double-blind, randomized, placebo-controlled trial involving 104 adult smokers.
• Participants were assigned to use either a 5% nicotine EC or a 0% nicotine EC for 6 weeks.
• Primary outcome: NNAL (a tobacco-related toxicant) levels in urine; Secondary outcomes: cotinine, exhaled CO, cigarette consumption, and volatile organic compounds.

Main Results:

• The 5% nicotine EC group showed a significantly higher rate of cigarette abstinence (36.5% vs 11.5%).
• Reduced levels of specific biomarkers for acrylonitrile and acrolein exposure were observed in the 5% nicotine EC group.
• Higher cotinine levels indicated nicotine intake, but no significant difference in cigarette consumption or exhaled CO was found.

Conclusions:

• Switching to a 5% nicotine EC led to reduced exposure to certain cigarette-derived toxicants and increased smoking cessation.
• Nicotine-delivering ECs may play a role in reducing harmful toxicant exposure associated with cigarette smoking.
• Further research is needed to understand the long-term implications of EC use.